FAKDX
Price
$11.53
Change
-$0.00 (-0.00%)
Updated
Jun 4 closing price
Net Assets
90.66M
VIVAX
Price
$66.86
Change
-$0.13 (-0.19%)
Updated
Jun 5 closing price
Net Assets
188.77B
Interact to see
Advertisement

FAKDX vs VIVAX

Header iconFAKDX vs VIVAX Comparison
Open Charts FAKDX vs VIVAXBanner chart's image
Kempner Multi-Cap Deep Value Investor
Price$11.53
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets90.66M
Vanguard Value Index I
Price$66.86
Change-$0.13 (-0.19%)
VolumeN/A
Net Assets188.77B
FAKDX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAKDX vs. VIVAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAKDX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. FAKDX (90.7M). VIVAX pays higher dividends than FAKDX: VIVAX (2.16) vs FAKDX (2.03). FAKDX was incepted earlier than VIVAX: FAKDX (17 years) vs VIVAX (33 years). FAKDX (1.22) is less costly to investors than VIVAX (0.17). FAKDX is a more actively managed with annual turnover of: 37.00 vs. VIVAX (9.00). FAKDX has a lower initial minimum investment than VIVAX: FAKDX (500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.90 vs. FAKDX (-1.62). VIVAX return over 5 years is better than : 59.01 vs. FAKDX (28.13).
FAKDXVIVAXFAKDX / VIVAX
Total Expense Ratio1.220.17718%
Annual Report Gross Expense Ratio1.220.17718%
Fund Existence17 years33 years-
Gain YTD0.9711.43468%
Front LoadN/AN/A-
Min. Initial Investment500300017%
Min. Initial Investment IRAN/AN/A-
Net Assets90.7M189B0%
Annual Yield % from dividends2.032.1694%
Returns for 1 year-1.626.90-23%
Returns for 3 years8.3920.0842%
Returns for 5 years28.1359.0148%
Returns for 10 years27.42103.6626%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PATH13.260.21
+1.61%
UiPath
NYMT6.670.08
+1.21%
New York Mortgage Trust
CSPI13.860.05
+0.36%
CSP
GRBK59.680.10
+0.17%
Green Brick Partners
ADIL0.66-0.01
-1.47%
Adial Pharmaceuticals